Real-world treatment patterns and survival outcomes in patients with locally advanced squamous cell carcinoma of the head and neck in Germany using claims data
Kathrin Hering(University Hospital Leipzig), N. Schoenherr(Merck KGaA, Darmstadt (Germany)), Marie-Noelle Solbes(Merck KGaA, Darmstadt (Germany)), Lena M. Richter, Michael Schultze(Berlin Center for Epidemiology and Health Research), Thomas Kuhnt(Leipzig University), Nils Kossack(Research Institute for System Studies), Ann‐Christin Gaupel(German Cancer Research Center), L. Henkel(Merck KGaA, Darmstadt (Germany)), Ulrike Osowski(Merck KGaA, Darmstadt (Germany)), Bernard Żołyniak(Merck KGaA, Darmstadt (Germany))
Cited by 8
Related Papers
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
|International Journal of Radiation Oncology*Biology*Physics|2000|218
Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis
|International Journal of Radiation Oncology*Biology*Physics|2003|197
Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer
|Radiation Oncology|2016|130